Randomized, placebo-controlled, single-ascending-dose study of BMS-791325, a hepatitis C virus (HCV) NS5B polymerase inhibitor, in HCV genotype 1 infection. [electronic resource]
Producer: 20170313Description: 3496-503 p. digitalISSN:- 1098-6596
- Adult
- Antiviral Agents -- administration & dosage
- Benzazepines -- administration & dosage
- Cohort Studies
- Double-Blind Method
- Drug Resistance, Viral
- Female
- Genotype
- Half-Life
- Hepacivirus -- classification
- Hepatitis C -- drug therapy
- Humans
- Indoles -- administration & dosage
- Interferons
- Male
- Middle Aged
- Phenotype
- RNA, Viral -- blood
- RNA-Dependent RNA Polymerase -- antagonists & inhibitors
- Viral Nonstructural Proteins -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.